Bausch + Lomb Cash Flow Statement
NYSE: BLCOHealth CareOphthalmic GoodsUSD
17.30+0.15 (+0.87%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch + Lomb free cash flow
In fiscal 2025, Bausch + Lomb generated $283.0 million of operating cash flow and spent $349.0 million on capital expenditures. That left free cash flow of -$66.0 million, a free-cash-flow margin of -1.3% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch + Lomb cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Net Income | -352.00M | -305.00M | -248.00M | 15.00M | 193.00M | -17.00M |
| Net Income growth (YoY) | — | — | -1753.33% | -92.23% | — | — |
| Depreciation & Amortization | 421.00M | 436.00M | 382.00M | 379.00M | 415.00M | 442.00M |
| Stock-Based Compensation | 149.00M | 92.00M | 74.00M | 62.00M | 62.00M | 50.00M |
| Change in Working Capital | 18.00M | -87.00M | -287.00M | -19.00M | 28.00M | -59.00M |
| Operating Cash Flow | 283.00M | 232.00M | -17.00M | 345.00M | 873.00M | 522.00M |
| Capital Expenditures | -349.00M | -291.00M | -181.00M | -175.00M | -193.00M | -253.00M |
| Investing Cash Flow | -455.00M | -412.00M | -2.11B | -215.00M | -214.00M | -256.00M |
| Debt Issued | 3.36B | 631.00M | 2.28B | 2.44B | 0 | 0 |
| Debt Repaid | -3.10B | -430.00M | -161.00M | -13.00M | 0 | 0 |
| Financing Cash Flow | 225.00M | 178.00M | 2.08B | 81.00M | -712.00M | -232.00M |
| Net Change in Cash | 81.00M | -18.00M | -46.00M | 203.00M | -61.00M | 46.00M |
| Free Cash Flow | -66.00M | -59.00M | -198.00M | 170.00M | 680.00M | 269.00M |
This table shows 6 annual periods of Bausch + Lomb's cash flow statement, from FY 2025 back to FY 2020, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow BLCO's reporting calendar. What is a cash flow statement?